Dyno Therapeutics

Building high-performance genetic technologies that transform patient lives

Cambridge, United States · Founded 2018 · $109.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Website
dynotx.com
Total Funding
$109.0M
Last Round
$100.0M Series AMay 2021
Rounds
2

About

Dyno Therapeutics applies AI and high-throughput in vivo experimentation to engineer novel AAV capsids for gene therapy, creating vectors with improved tissue targeting, safety, and efficacy. The company operates a partnership-centric model, licensing its capsid technology to pharma leaders including Novartis, Sarepta, Roche, Spark, and Astellas under deals collectively valued at over $4 billion.

Summary

Dyno Therapeutics is an Artificial Intelligence company based in Cambridge, United States, founded in 2018. It has raised $109.0M in total across 2 rounds, most recently a $100.0M Series A round in May 2021. Investors include Polaris Partners, CRV (Charles River) and Andreessen Horowitz.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AMay 2021
$100.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dyno Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/dyno-therapeutics"><img src="https://indexed.vc/api/badge/company/dyno-therapeutics" alt="Dyno Therapeutics on Indexed.vc" width="260" height="76" /></a>